학술논문

Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study
Document Type
Article
Source
In: Digestive and Liver Disease. (Digestive and Liver Disease, November 2023, 55(11):1562-1572)
Subject
Language
English
ISSN
18783562
15908658